Literature DB >> 19169660

[Extending the limits of lymphadenectomy during radical cystectomy: pitfalls in the interpretation of contemporary study results].

H Suttmann1, J Kamradt, F Becker, J Lehmann, M Stöckle.   

Abstract

The optimal extent of lymphadenectomy performed during radical cystectomy for transitional cell carcinoma of the bladder is currently under intensive debate. Extending the limits of lymphadenectomy has been hypothesized to add further diagnostic and therapeutic benefit. However, our current knowledge is based exclusively on results from retrospective studies that are hampered by several statistical shortcomings. This article provides a critical analysis of the contemporary data on the subject and outlines typical statistical pitfalls that must be considered when interpreting such research results.

Entities:  

Mesh:

Year:  2009        PMID: 19169660     DOI: 10.1007/s00120-008-1902-3

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  12 in total

Review 1.  Optimal locoregional treatment in gastric cancer.

Authors:  Edwin P M Jansen; Henk Boot; Marcel Verheij; Cornelis J H van de Velde
Journal:  J Clin Oncol       Date:  2005-07-10       Impact factor: 44.544

2.  Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

Authors:  J P Stein; G Lieskovsky; R Cote; S Groshen; A C Feng; S Boyd; E Skinner; B Bochner; D Thangathurai; M Mikhail; D Raghavan; D G Skinner
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

3.  Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95).

Authors:  Jan Lehmann; Margitta Retz; Christina Wiemers; Joachim Beck; Joachim Thüroff; Christoph Weining; Peter Albers; Detlef Frohneberg; Tanja Becker; Peter-Jörg Funke; Peter Walz; Sigrun Langbein; Frank Reiher; Matthias Schiller; Kurt Miller; Stephan Roth; Tilman Kälble; Donald Sternberg; Stefan Wellek; Michael Stöckle
Journal:  J Clin Oncol       Date:  2005-06-06       Impact factor: 44.544

4.  Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis.

Authors:  J Leissner; R Hohenfellner; J W Thüroff; H K Wolf
Journal:  BJU Int       Date:  2000-05       Impact factor: 5.588

5.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

Authors:  A R Feinstein; D M Sosin; C K Wells
Journal:  N Engl J Med       Date:  1985-06-20       Impact factor: 91.245

6.  Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy.

Authors:  Harry W Herr
Journal:  Urology       Date:  2003-01       Impact factor: 2.649

7.  Will Rogers and the results of radical cystectomy for invasive bladder cancer.

Authors:  K I Wishnow; D M Tenney
Journal:  Urol Clin North Am       Date:  1991-08       Impact factor: 2.241

8.  Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference.

Authors:  D G Skinner
Journal:  J Urol       Date:  1982-07       Impact factor: 7.450

Review 9.  Improving the prognosis of patients after radical cystectomy. Part I: the role of lymph node dissection.

Authors:  Henrik Suttmann; Jörn Kamradt; Jan Lehmann; Michael Stöckle
Journal:  BJU Int       Date:  2007-12       Impact factor: 5.588

10.  Outcome after radical cystectomy with limited or extended pelvic lymph node dissection.

Authors:  Nivedita Bhatta Dhar; Eric A Klein; Alwyn M Reuther; George N Thalmann; Stephan Madersbacher; Urs E Studer
Journal:  J Urol       Date:  2008-01-25       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.